Readoutin 135d
Takeda — TDV
Phase 3 primary completion: A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years).
- Date
- Apr 2027
- Type
- Readout
- Indication
- Dengue Fever
Readoutin 135d
Phase 3 primary completion: A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years).
The weekly brief is free. Pro adds reminders 7 days and 1 day before.